Antinuclear antibodies
Nishikai, M.; Abe, T.
Rinsho Byori. Japanese Journal of Clinical Pathology 33(4): 384-389
1985
ISSN/ISBN: 0047-1860 PMID: 3876459 Document Number: 260675
Document emailed within 1 workday
Related Documents
Le Goff, P.; Muller, S.; Lelong, A.; Jouquan, J.; Youinou, P. 1988: Among the antinuclear antibodies in rheumatoid polyarthritis: antihistone antibodies detected by an immunoenzymatic technic Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(11): 919-922Wojas-Pelc, A.; Wielowieyska-Szybińska, D.; Kiełtyka, A. 2002: Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini Przeglad Lekarski 59(11): 898-902
Doutre, M.-S. 2003: Antinuclear antibodies Annales de Dermatologie et de Venereologie 130(3): 388-390
Gülmezoğlu, E.; Ergüven, S. 1985: The diagnostic value of antinuclear antibodies Mikrobiyoloji Bulteni 19(1): 41-48
Rosenberg, A.M.; Bingham, M.C.; Fong, K.C. 1986: Antinuclear antibodies during pregnancy Obstetrics and Gynecology 68(4): 560-562
Prohaska, E.; Neumüller, J.; Partsch, G.; Eberl, R. 1980: Antinuclear antibodies in ankylosing spondylitis Wiener Klinische Wochenschrift 92(24): 876-879
Meryhew, N.L.; Messner, R.P.; Tan, E.M. 1983: Urinary excretion of antinuclear antibodies Journal of Rheumatology 10(6): 913-919
Jordon, R.E.; Deheer, D.; Schroeter, A.; Winkelmann, R.K. 1971: Antinuclear antibodies: their significance in scleroderma Mayo Clinic Proceedings 46(2): 111-113
Sehgal, S.; Aikat, B.K.; Pasricha, N. 1978: Diagnostic significance of antinuclear antibodies Indian Journal of Medical Research 67: 116-123
Ferec, C.; Youinou, P.; Le Goff, P.; Miossec, P.; Morin, J.F.; Pennec, Y.; Morin, P.P.; Le Menn, G. 1984: Significance of antinuclear anti-histone antibodies Annales de Medecine Interne 135(6): 427-430
Rosenberg, A.M.; Uziel, Y.; Krafchik, B.R.; Hauta, S.A.; Prokopchuk, P.A.; Silverman, E.D.; Laxer, R.M. 1995: Antinuclear antibodies in children with localized scleroderma Journal of Rheumatology 22(12): 2337-2343
Aho, K.; Koskela, P.; Mäkitalo, R.; Heliövaara, M.; Palosuo, T. 1992: Do antinuclear antibodies precede systemic lupus? Duodecim; Laaketieteellinen Aikakauskirja 108(2): 157-160
Pelísková, Z.; Trnavský, K.; Vácha, J. 1985: Rheumatoid arthritis with antinuclear antibodies in the blood Vnitrni Lekarstvi 31(8): 756-761
Acosta-Mérida, A.; Isenberg, D.A. 2013: Antinuclear antibodies seroconversion in 100 patients with lupus Clinical and Experimental Rheumatology 31(4): 656
Manzano Espinosa, L.; Yebra Bango, M.; Merino Morales, F.; Lladós Comenge, G.; de Diego Marín, F.J.; Durántez Martínez, A. 1986: Amiodarone pulmonary disease and antinuclear antibodies Revista Clinica Espanola 179(1): 54-55
Alarcon-Segovia, D.; Fishbein, E. 1975: Patterns of antinuclear antibodies and lupus-activating drugs Journal of Rheumatology 2(2): 167-171
Duc, J.; Perroulaz, G.; Golaz, J.; Campiche, M.; Pécoud, A. 1987: Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies Schweizerische Medizinische Wochenschrift 117(6): 205-208
Wananukul, S.; Voramethkul, W.; Kaewopas, Y.; Hanvivatvong, O. 2005: Prevalence of positive antinuclear antibodies in healthy children Asian Pacific Journal of Allergy and Immunology 23(2-3): 153-157
Imran, A.; Neelam, F.; Tariq, M. 2003: Incidence of circulating antinuclear antibodies in cancer patients Indian Journal of Medical Sciences 57(3): 113-116
Alarcón-Segovia, D.; Fishbein, E.; Cetina, J.A.; Raya, R.J.; Barrera, E. 1973: Antigenic specificity of chlorpromazine-induced antinuclear antibodies Clinical and Experimental Immunology 15(4): 543-548